Home
Law & policy

Law & policy

New IAM legal research tool aids busy patent professionals in the global licensing landscape

“Primary Sources” can fast-forward your queries about jurisdictions around the world

AI is posing many challenges but we are finding ways to overcome them, says US Copyright Office Director

Shira Perlmutter, one of this year’s IP Hall of Fame inductees, speaks to IAM about her career and the big issues currently facing the copyright world

Dutch businesses increasingly proactive about trade secret misappropriation

The volume of cases appears to be picking up pace in the Netherlands with key rulings offering guidance on confidentiality clubs and patenting of misappropriated trade secrets

Latest content

Revised guidelines for trademark disputes set to improve hearing process

The Taiwan Ministry of Economic Affairs has published its amended guidelines that govern hearings in trademark cases. The revisions aim to streamline and enhance the process of deciding disputes by introducing remote and preliminary hearings and provisions on judges’ disclosure of inner convictions.

03 July 2024

Teva to be investigated by FTC, ramping up scrutiny of Orange Book listings

Antitrust challenges against pharma patent strategies continue to escalate

02 July 2024

Experts predict more litigation against USPTO rules. But will it succeed?

After the US Supreme Court overturned the Chevron doctrine on 28 June there are differing opinions on how USPTO rule-making packages will be impacted

01 July 2024

Federal Circuit’s latest skinny label decision is another headache for generics

Appellate court hands down guidance on induced infringement cases

28 June 2024

UPC to miss timeline targets in several SEP cases, despite prioritising speedy proceedings

SEP disputes and other complex infringement spats are taking longer than expected at Europe’s new court

27 June 2024

Culture is crucial for patent team leadership, says Nokia’s Jenni Lukander

The 2024 IP Hall of Fame inductee speaks to IAM about everything from Finnish philosophy to new areas of SEP licensing as well as the threat posed by the EU’s proposed SEP licensing regulation

25 June 2024

What rights holders need to know about patent-term extensions in Europe

Featured in The Guide to Life Sciences: Key issues for senior life sciences executives 2024

24 June 2024

Comparison of Canadian and US approaches to patentability and infringement issues

Featured in The Guide to Life Sciences: Key issues for senior life sciences executives 2024

Canada and the United States share common characteristics in their legal systems, with many overlapping rules in patent law. However, inventors, patent holders and practitioners should also be aware of three fundamental differences that may have practical implications on IP strategy: whether a prior sale of a product bars patentability, the question of how similar a product could be without infringing on a patented invention and infringement in the context of the skinny-label pathway.

24 June 2024

A deep dive into patent law and exclusivity in the United States

Featured in The Guide to Life Sciences: Key issues for senior life sciences executives 2024

Life science legislation is nuanced and must be carefully navigated to when creating an effective patent portfolio. Having a keen understanding of regulatory provisions is key to navigating the many minefields inherent in the commercialisation of a successful product.

24 June 2024

Australia: a toolkit for prosecution and enforcement amid patentability barriers

Featured in The Guide to Life Sciences: Key issues for senior life sciences executives 2024

Australia remains an in-demand jurisdiction for patent protection in the life sciences, as its patent system supports applicants and patentees with a legal framework that is closely harmonised with major jurisdictions – as standards for novelty and inventive step tend to follow a European approach, with key differences.

24 June 2024

Unlock unlimited access to all IAM content